Cite
MLA Citation
Christopher Edwards et al.. “FRI0088 SAFETY, IMMUNOGENICITY AND EFFICACY OF THE PROPOSED BIOSIMILAR MSB11022 (MODIFIED FORMULATION) COMPARED WITH ADALIMUMAB REFERENCE PRODUCT IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE RHEUMATOID ARTHRITIS: AURIEL-RA, A RANDOMISED, DOUBLE-BLIND, PHASE III STUDY.” Annals of the rheumatic diseases, vol. 78, n.d., p. 707. http://access.bl.uk/ark:/81055/vdc_100144715899.0x000056